Clinical pharmacokinetics of vasodilators: part I

R Kirsten, K Nelson, D Kirsten, B Heintz - Clinical pharmacokinetics, 1998 - Springer
Understanding the mechanism of action and the pharmacokinetic properties of vasodilatory
drugs facilitates optimal use in clinical practice. It should be kept in mind that a drug belongs …

Neuroprotective effect of honokiol and magnolol, compounds from Magnolia officinalis, on beta‐amyloid‐induced toxicity in PC12 cells

CP Hoi, YP Ho, L Baum, AHL Chow - Phytotherapy Research, 2010 - Wiley Online Library
Amyloid β peptide (Aβ) induced toxicity is a well‐established pathway of neuronal cell death
which might play a role in Alzheimer's disease. In this regard, the toxic effect of Aβ on a …

ACE inhibition for severe bronchopulmonary dysplasia–an approach based on physiology

A Sehgal, MB Krishnamurthy, M Clark… - Physiological …, 2018 - Wiley Online Library
Premature infants have a high incidence of bronchopulmonary dysplasia (BPD). Systemic
hypertension, arterial thickness and stiffness, and increased systemic afterload may all …

Bioanalysis of captopril: two sensitive high-performance liquid chromatographic methods with pre-or postcolumn fluorescent labeling

RJ Kok, J Visser, F Moolenaar, D de Zeeuw… - … of Chromatography B …, 1997 - Elsevier
This study describes the development and comparison of two HPLC methods for the
analysis of the antihypertensive drug captopril. The first method is based on a precolumn …

Heart failure pharmacotherapy: differences between adult and paediatric patients

M Bajcetic, T Vidonja Uzelac… - Current Medicinal …, 2014 - ingentaconnect.com
During the last decades, the introduction of new, more efficient drugs, has significantly
improved the heart failure (HF) therapy of adults. Therapeutic focus has shifted from simple …

Case studies of categorical data-derived adjustment factors

BD Naumann, KC Silverman, R Dixit… - … and Ecological Risk …, 2001 - Taylor & Francis
Investigations were performed on representative compounds from five different therapeutic
classes to evaluate the use of categorical data-derived adjustment factors to account for …

Angiotensin converting enzyme inhibitor (ACEI)-induced acute renal failure in premature newborns with congenital heart disease

GJ Lee, R Cohen, AC Chang… - The Journal of Pediatric …, 2010 - meridian.allenpress.com
We report three cases of angiotensin converting enzyme inhibitor (ACEI) induced
nephrotoxicity in preterm infants with congenital heart disease. Patients developed acute …

[PDF][PDF] Captopril Determination in Dried Blood Spot Samples with LC-MS and LCHRMS: A Potential Method for Neonate Pharmacokinetic Studies

G Lawson, H Mulla, S Tanna - Journal of Bioanalysis & Biomedicine, 2012 - hal.science
The use of blood spot collection cards was investigated as a means of obtaining small
volume samples for the analysis of therapeutic drugs for the purpose of neonatal …

[PDF][PDF] Influence of Age, Heart Failure and ACE Inhibitor Treatment on Plasma Renin Activity in Children: Insights from a Systematic Review and the European LENA …

M Steichert, W Cawello, M Bajcetic, JMPJ Breur… - 2023 - repository.ubn.ru.nl
BACKGROUND: Plasma renin activity (PRA) has gained relevance as prognostic marker in
adults with heart failure. The use of PRA as a clinically meaningful parameter in children and …

Pharmacokinetic–pharmacodynamic modelling for captopril in healthy anaesthetized piglets

CM Pereira, YK Tam, JY Coe, PM Olley… - … & drug disposition, 1996 - Wiley Online Library
The use of the angiotensin converting enzyme inhibitor, captopril, specially in children, has
been empirical. This is because the relationship between the pharmacokinetics and …